C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
10/2002
10/29/2002	US6472545 For therapy of diabetes, obesity
10/29/2002	US6472543 Lactone compounds having alicyclic structure and their manufacturing method
10/29/2002	US6472534 Treating tetrahydrofuran derivativ with an oxophilic electrophilic reagent in a manner that is effective to provide the oxazoline compound
10/29/2002	US6472414 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
10/29/2002	US6472407 α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/29/2002	CA2291068C Method for the preparation of citalopram
10/25/2002	WO2001083451A1 Novel bicyclic compounds
10/24/2002	WO2002083659A1 Diamine, acid dianhydride, polyimide composition having reactive group obtained therefrom, and processes for producing these
10/24/2002	WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
10/24/2002	WO2002083622A2 Novel aminophenyl ketone derivatives
10/24/2002	WO2002083123A1 Aurones as telomerase inhibitors
10/24/2002	WO2002026726A3 Antiviral compositions and methods of use
10/24/2002	US20020156296 Kidney disease, organ transplant
10/24/2002	US20020156295 Coordination catalyst containing ligand
10/24/2002	US20020156098 Antiprotozoa agents, parasiticides
10/24/2002	US20020156054 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
10/24/2002	US20020156050 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors
10/24/2002	US20020156018 Treating parasitic diseases, which are mediated by such proteases. In particular, treating malaria by inhibiting the cysteine protease falcipain.
10/24/2002	US20020155379 Photosensitive monomer, photosensitive polymer and chemically amplified resist composition comprising lactone group having acid-labile protecting group
10/24/2002	US20020154638 Method and system for a low-overhead mobility management protocol in the internet protocol layer
10/24/2002	DE10119737A1 Purification of an organic solvent used for the absorption of maleic acid anhydride from a gaseous mixture, comprises separation of a low and high boiling fractions from essentially pure solvent.
10/24/2002	CA2441274A1 Aurones as telomerase inhibitors
10/23/2002	EP1251128A1 Cyclohexylamine derivatives as subtype selective N-methyl-D-aspartate antagonists
10/23/2002	EP1251127A1 Novel sidechain-bearing taxanes and intermediates thereof
10/23/2002	EP1251126A2 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
10/23/2002	EP1250331A1 Formulation for protection against oxidative stress containing benzofuranone derivatives
10/23/2002	EP1250330A1 Process for the preparation of 3-furoate esters and novel intermediate compounds
10/23/2002	EP1250324A1 Biaryl compounds, their preparation and their use in therapy
10/23/2002	EP1250316A1 Method for producing n-alkoxy-n-alkylamides
10/23/2002	EP0783499B1 Benzofuran derivatives as tachykinin antagonists
10/23/2002	CN1376146A Solid-state form of celecoxil having enhanced bioavailability
10/23/2002	CN1093126C Improved process for the synthesis of protected esters of (s)-3,4-dihydroxytubyric acid
10/23/2002	CN1092960C Pharmaceutical composition comprising proteinase inhibitor and monoglyceride
10/22/2002	US6469205 Method for oxidation of xylene derivatives
10/22/2002	US6469196 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
10/22/2002	US6469193 Efficient synthesis of alkyl carbonates
10/22/2002	US6469054 Aryl sulphonamides and analogues
10/22/2002	US6469047 Tyrosine derivatives
10/22/2002	US6469028 Synthesis and use of retinoid compounds having negative hormone and/or anatgonist activities
10/22/2002	US6469005 Propargylether derivatives
10/22/2002	CA2291129C Method for the preparation of citalopram
10/22/2002	CA2227264C Amine acid salt compounds and process for the production thereof
10/17/2002	WO2002081463A1 Antagonists of mcp-1 function and methods of use thereof
10/17/2002	WO2002081435A1 Sulphones which modulate the action of gamma secretase
10/17/2002	WO2002081428A1 Benzene compound and salt thereof
10/17/2002	WO2002081398A2 Additives for building industry obtained from by-products and process for their production
10/17/2002	WO2002080929A1 Remedies or preventives for interstitial nephritis
10/17/2002	WO2002080927A1 Use of selective cox-2 inhibitors for the treatment of urinary incontinence
10/17/2002	WO2002080912A1 Reconstitutable parenteral composition containing a cox-2 inhibitor
10/17/2002	WO2002080904A1 Liver funcion protecting or ameliorating agent
10/17/2002	WO2002059114A9 Lfa-1 antagonist compounds
10/17/2002	WO2001096283A9 Hiv integrase inhibitors
10/17/2002	WO2001041760A8 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/17/2002	US20020151741 Process for producing cyclopropanecarboxylates
10/17/2002	US20020151729 Via crystallization with ethanol/isopropanol and hydrogen cyanide; antagonists of the histamine receptor useful in treatment of gastric and peptic ulcers
10/17/2002	US20020151728 Production methods of 5-phthalancarbonitrile compound and an intermediate therefor
10/17/2002	US20020151727 3-acetyl-n-substituted-3-aminomethyltetrahydrofuran-2-one derivative and production process therefor
10/17/2002	US20020151726 Continuous process for producing L-ascorbic acid
10/17/2002	US20020151718 Synthesis of pyrrole amides
10/17/2002	US20020151586 Antidiabetic agents
10/17/2002	US20020151584 Salvia plant extracts; ester benzofuran derivatives
10/17/2002	US20020151580 Synthetic spiroketal pyranes as potent anti-cancer agents and use
10/17/2002	US20020151570 Thiosulfonic acid S-esters as agents for protecting material
10/17/2002	US20020151566 Phosphodiesterase 4 inhibitors
10/17/2002	US20020151504 Amino acid containing compounds useful as modulators of the immune system
10/17/2002	DE10114970A1 New 1,2-diamino-4-azolyl-, -4-furyl-, -4-thienyl-, -4-phenyl- and -4-azinyl-benzene compounds and known analogues are used in oxidative colorants for keratin fibers, especially human hair
10/17/2002	CA2443031A1 Use of selective cox-2 inhibitors for the treatment of urinary incontinence
10/17/2002	CA2442776A1 Antagonists of mcp-1 function and methods of use thereof
10/16/2002	EP1249449A1 Method for obtaining 2-bromo-5-(2-bromo-2-nitrovinyl)-furan
10/16/2002	EP1249448A1 3-Acetyl-n-substituted-3-aminomethyltetrahydroguran-2-one derivative and process therefor
10/16/2002	EP1249233A1 Npyy5 antagonists
10/16/2002	EP1248777A2 Tricyclic compounds with antiviral activity
10/16/2002	EP1248763A2 Aromatic di-keto derivatives as glucose-6-phosphate translocase inhibitors
10/16/2002	EP1248677A1 Vanadium-phosphorus oxide catalysts with promoter reagents
10/16/2002	EP1248607A1 Urotensin-ii receptor antagonists
10/16/2002	EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/16/2002	EP0831826B1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
10/16/2002	EP0813542B1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/16/2002	CN1092655C 哌啶衍生物 Piperidine derivatives
10/16/2002	CN1092639C Benzene-fused heterocyclic derivative and use thereof
10/16/2002	CN1092634C Preparation of maleic anhydride with n-butane gas phase catalytic oxidation by in site calcination and activation with catalyst
10/15/2002	US6465508 Nonpeptide inhibitors of gelatinases, stromelysins and colla-genases; arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, proteinuria, aneurysmal aortic disease, hiv
10/15/2002	US6465468 Hydroxamic and carboxylic acid derivatives
10/15/2002	US6465433 Boronic ester and acid compounds, synthesis and uses
10/15/2002	CA2112690C Amino acid derivative
10/10/2002	WO2002080160A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
10/10/2002	WO2002079198A1 Pyridazinone aldose reductase inhibitors
10/10/2002	WO2002079182A2 Transition-metal-catalyzed process for the preparation of sterically hindered n-substituted alkoxyamines
10/10/2002	WO2002079181A1 Benzofuran derivatives
10/10/2002	WO2002079179A1 Alkylxanthates and their use as pesticides
10/10/2002	WO2002079145A1 BENZAMIDE INHIBITORS OF FACTOR Xa
10/10/2002	WO2002079144A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/10/2002	WO2002079143A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/10/2002	WO2002079142A1 A process for the production of amides from amines
10/10/2002	WO2002078832A2 Supercritical fluids or dense phase gases formed from liquid precursors
10/10/2002	WO2002078693A2 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
10/10/2002	WO2002078626A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002	WO2002078625A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002	WO2002078605A2 Premixed amiodarone parenteral solution and method for making the same
10/10/2002	WO2002062763A3 Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas

1 ... 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 ... 472